Bio-Techne Corporation
TECH
$77.29
$1.692.24%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 272.60M | 276.94M | 301.32M | 294.15M | 271.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 272.60M | 276.94M | 301.32M | 294.15M | 271.58M |
| Cost of Revenue | 94.65M | 91.56M | 96.62M | 91.98M | 88.12M |
| Gross Profit | 177.94M | 185.37M | 204.70M | 202.16M | 183.46M |
| SG&A Expenses | 104.89M | 105.83M | 97.82M | 100.57M | 84.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 222.46M | 221.39M | 217.86M | 215.27M | 195.28M |
| Operating Income | 50.14M | 55.54M | 83.46M | 78.88M | 76.30M |
| Income Before Tax | 33.39M | 49.56M | 88.32M | 80.20M | 66.43M |
| Income Tax Expenses | 5.92M | -1.44M | 12.83M | 9.98M | 16.42M |
| Earnings from Continuing Operations | 27.47M | 50.99M | 75.48M | 70.22M | 50.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | -- | -- |
| Net Income | 27.47M | 50.99M | 75.48M | 70.22M | 50.01M |
| EBIT | 50.14M | 55.54M | 83.46M | 78.88M | 76.30M |
| EBITDA | 77.94M | 84.08M | 110.39M | 105.85M | 103.00M |
| EPS Basic | 0.17 | 0.32 | 0.48 | 0.45 | 0.32 |
| Normalized Basic EPS | 0.18 | 0.19 | 0.31 | 0.31 | 0.30 |
| EPS Diluted | 0.17 | 0.31 | 0.46 | 0.43 | 0.31 |
| Normalized Diluted EPS | 0.18 | 0.19 | 0.30 | 0.30 | 0.29 |
| Average Basic Shares Outstanding | 157.53M | 158.13M | 157.50M | 157.31M | 157.01M |
| Average Diluted Shares Outstanding | 160.06M | 161.94M | 161.92M | 161.62M | 161.75M |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 45.73% | 24.82% | 16.69% | 17.92% | 25.12% |
